Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Debt / NOTE 4/0
-
Number of holders
-
34
-
Total 13F principal, excl. options
-
505,668,900
-
Principal change
-
+505,668,900
-
Total reported value, excl. options
-
$464,773,416
-
Value change
-
+$464,773,417
-
Number of buys
-
34
-
Price
-
$0.9126
Significant Holders of IONIS PHARMACEUTICALS INC - NOTE 4/0 as of Q2 2022
34 filings reported holding 462222AD2 - IONIS PHARMACEUTICALS INC - NOTE 4/0 as of Q2 2022.
IONIS PHARMACEUTICALS INC - NOTE 4/0 has 34 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $505,668,900 of principal
.
Largest 10 bondholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ($127,800,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($107,030,000 of principal), TENOR CAPITAL MANAGEMENT Co., L.P. ($55,000,000 of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($25,000,000 of principal), BlackRock Inc. ($22,425,000 of principal), MACKAY SHIELDS LLC ($20,373,000 of principal), WHITEBOX ADVISORS LLC ($17,855,000 of principal), Magnetar Financial LLC ($16,700,000 of principal), CAPSTONE INVESTMENT ADVISORS, LLC ($16,200,000 of principal), and AMERIPRISE FINANCIAL INC ($15,908,000 of principal).
This table shows the top 34 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.